Rentokil Initial PLC
21 June 2005
RENTOKIL INITIAL plc
Capital Reorganisation of the Rentokil Initial group
Scheme of Arrangement becomes effective
At a hearing of the High Court (the 'Court') on 20 June 2005, the Court
sanctioned the proposed scheme of arrangement of Rentokil Initial plc ('Rentokil
Initial') under section 425 of the Companies Act 1985 (the 'Scheme') to
introduce a new listed group holding company, Rentokil Initial 2005 plc ('New
Rentokil Initial').
The Scheme became effective at 8.00am today, 21 June 2005, and the new New
Rentokil Initial shares were admitted to the Official List and to trading on the
London Stock Exchange's market for listed securities at that time. In addition,
the name of New Rentokil Initial was changed to Rentokil Initial plc and the
name of Rentokil Initial to Rentokil Initial 1927 plc at that time.
Under the terms of the Scheme, holders of Rentokil Initial shares at the Scheme
Record Time (which was 6.00pm on 20 June 2005) have received one new New
Rentokil Initial share for each Rentokil Initial share held and cancelled
pursuant to the Scheme.
The Court is expected to approve the reduction of capital of New Rentokil
Initial (the 'Reduction of Capital') at a hearing on 22 June 2005. The Reduction
of Capital is expected to become effective on 23 June 2005, whereupon the
nominal value of a New Rentokil Initial ordinary share will be reduced from
GBP1.00 to 1 penny.
For further information please contact:
Rentokil Initial
Roger Payne, Finance Director Tel: 01342 833022
Charles Grimaldi, Investor Relations Tel: 01342 833022
UBS Investment Bank
Emma Goodrick Tel: 020 7567 8000
Jonathan Bewes Tel: 020 7567 8000
UBS Limited is acting for Rentokil Initial and New Rentokil Initial and no-one
else in connection with the Scheme and the Reduction of Capital and,
accordingly, will not be responsible to anyone other than Rentokil Initial and
New Rentokil Initial for providing the protections afforded to its clients nor
for providing advice in relation to the Scheme or the Reduction of Capital or
any other matters referred to in the Listing Particulars published by New
Rentokil in connection with the reorganisation, the circular sent by Rentokil
Initial relating to the Scheme or herein.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.